Space — Biotech's Final Frontier

Space, it's not just for the physical sciences anymore. That's right, the Microgravity Research Competition is looking to reward innovation in the use of microgravity to advance biotechnology as well as other fields. The competition is sponsored by the Heinlein Prize Trust and Space Exploration Technologies (SpaceX), and offers a $25,000 prize and transportation to and from Low Earth Orbit for the winning experiment aboard a SpaceX Dragon spacecraft.

"Decades of demonstrations have shown that the microgravity of space provides a unique window on biological and physical processes," said Art Dula, Trustee of the Heinlein Prize Trust. "Because of substantial recent funding by NASA and the private sector, access to microgravity will soon be more commonplace. This opens an incredibly exciting opportunity for the research community," Dula said.

Why space? In space, there is no gravity-induced convection, sedimentation, hydrodynamic shear force, hydrostatic pressure, or mass transfer. Consequently, experiments in microgravity can reveal novel mechanisms fundamental to cell processes, disease processes, and the adaptation of living systems to changes in physical forces.

The winning experiment will be launched into Earth orbit aboard a SpaceX Falcon 9 rocket and Dragon spacecraft. NASA recently selected Falcon 9 / Dragon to transport cargo to the International Space Station.

The Microgravity Research Competition is open to U.S. universities and non-profits organizations with industry partners. The winning team will also get to witness the launch of their experiment from Cape Canaveral, Fla.

The announcement, available at www.labflight.com, provides an overview of microgravity's practical applications and details on the competition. Proposals are due on March 20, 2009.

The application and judging process will be supported by the Rice Alliance for Technology and Entrepreneurship. The winner will be announced on April 18, 2009 at the Awards Banquet for the 2009 Rice Business Plan Competition hosted by the Rice Alliance.

Biotechnology Industry Organization

Views: 45

Comment

You need to be a member of 12160 Social Network to add comments!

Join 12160 Social Network

"Destroying the New World Order"

TOP CONTENT THIS WEEK

THANK YOU FOR SUPPORTING THE SITE!

mobile page

12160.info/m

12160 Administrators

 

Latest Activity

Burbia commented on Burbia's group The Comment Section is Closed
"So far, there are 14 comments here for the video about Iran's influence on Generation Z and…"
10 hours ago
Doc Vega posted blog posts
10 hours ago
tjdavis posted videos
23 hours ago
tjdavis posted photos
yesterday
Larry Harmen posted blog posts
yesterday
Larry Harmen posted videos
yesterday
Doc Vega posted blog posts
yesterday
cheeki kea commented on Less Prone's photo
Thumbnail

Rebuilding Khazaria

"Perhaps Russia and Ukraine should Rebuild the Tartarian Empire. Then game over. "
yesterday
cheeki kea commented on FREEDOMROX's blog post NEVER FORGET! WHO and UN charged with GENOCIDE in 2009
"This is Why the outlier countries Must Stand Up And Fight Them Off on all fronts at all times. For…"
yesterday
cheeki kea posted a blog post

Dr. Aseem Malhotra's Explosive Court Testimony on COVID "Vaccines"(UPDATED)

 Doctor Malhotra drops arsenal of truth bombs on Helsinki. A spectacular display. Here are few snip…See More
yesterday
Less Prone favorited Doc Vega's blog post They Want to Murder Trump!
Tuesday
Less Prone posted a photo
Tuesday
rlionhearted_3 posted a photo
Tuesday
Doc Vega posted blog posts
Monday
Doc Vega commented on tjdavis's photo
Thumbnail

reminders

"Wow how ironic! "
Sunday
Less Prone commented on KLC's group MUSICWARS
"Walk like a Joe Biden"
Sunday
Less Prone favorited Sandy's photo
Sunday
Less Prone favorited cheeki kea's photo
Sunday
Less Prone replied to MAC's discussion GAIN OF FUNCTION CRIMINALS ARE SQUIRMING
Sunday
Sandy posted photos
Sunday

© 2024   Created by truth.   Powered by

Badges  |  Report an Issue  |  Terms of Service

content and site copyright 12160.info 2007-2019 - all rights reserved. unless otherwise noted